<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<!-- saved from url=(0068)https://era.bfs.de/studies_description_from_db.php?LabId=2&StudyId=7 -->
<html xml:lang="en" xmlns="http://www.w3.org/1999/xhtml" slick-uniqueid="3"><head><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1">


	
	<meta name="author" content="Michael Gruenberger mg287@cam.ac.uk">
	<meta name="keywords" content="european, radiation, database">
	<meta name="description" content="ERA: European Radiobiological Archives">
	<meta name="robots" content="all">
	<title>ERA: European Radiobiological Archives</title>

<script language="javascript" src="./2-7_files/alttxt.js"></script><style type="text/css"></style>
	
	<style type="text/css" title="currentStyle" media="screen">@import "index_wide.css";</style>
	<link rel="Shortcut Icon" type="image/x-icon" href="https://era.bfs.de/favicon.ico">	
<script type="text/javascript" src="chrome-extension://bfbmjmiodbnnpllbbbfblcplfjjepjdn/js/injected.js"></script><style id="bitmark_stylesheet" type="text/css"></style></head><body id="css-zen-garden" text="#000000" link="#0000ff" vlink="#551a8b" alink="#ff0000" bgcolor="#c0c0c0" style="">

<div id="container">
	<div id="intro">
		<div id="quickSummary">
		<p class="p2">
		  <a href="https://era.bfs.de/index.php" style="background: #1680c4 url(images/nav_home.gif) top left no-repeat;position:absolute;left:0px;top:-60px;border:0px;padding: 40px 40px 0 30px; width: 141px;
"></a>
		</p><div class="p3">		  <a style="padding-bottom:2px;margin-bottom:2px;">
		    <form action="https://era.bfs.de/studies_search.php" method="GET">
		    <input type="hidden" name="stage" value="3">
		    <input type="text" name="query" style="width:100px; position:relative;left:-20px;" onmouseover="writetxt(&#39;Searches study name and description. Combine multiple terms to run an AND query or specify an OR query, e.g. tumor OR tumour&#39;)" onmouseout="writetxt(0)">
		    <input type="submit" value="Search" style="position:relative;left:100px;top:-20px;">
		    </form>
		  </a>
		  <a style="padding:2px;" href="https://era.bfs.de/studies_search.php" onmouseover="writetxt(&#39;Searches study, group and individual organism data by pathology, anatomy, exposure etc.&#39;)" onmouseout="writetxt(0)">Advanced Search</a><br><br>
		  <a style="padding:2px;" href="https://era.bfs.de/studies_search.php?stage=3&type=browse" onmouseover="writetxt(&#39;List all studies sorted by lab.&#39;)" onmouseout="writetxt(0)">Browse Studies</a>

		<br><br><br><a href="https://era.bfs.de/contacts.php?t=feedback" onmouseover="writetxt(&#39;Comments, suggestions, improvements? Click here to send your feedback!&#39;)" onmouseout="writetxt(0)">Feedback</a>		</div>
		<p></p>
		</div>
	<div id="preamble">
			<h3><span>ERA: Studies Description</span></h3>
			
			<p style="font-size:.5em;font-weight:bold;width:300px;border:1px;background-color:#DFDBD3;float:right">Please note: The data below has been compiled for the original ERA CD and for printing the ERA book. The data in the database might have changed since then. Please follow the link at the bottom at the page to view the 'live' data.</p>
			<p class="p1"><span>
			<synopsis1>

<title></title>



</synopsis1></span></p><h3>02.07 Lung and Sinus Tumors in Rats After Inhalation or Topical Injection of Ce-144 and Treatment with Different
Cofactors</h3>

<p><strong>Institution: CEA, DSV-DTPE (IPSN) Fontenay-aux Roses, France</strong></p>

<p><strong>Scientists:</strong> M. Morin; J. Jasmin; W. Skupinski;&nbsp;</p>

<p><strong>Purpose:</strong> To determine the cancer risks from beta-emitters after inhalation or, to simulate uptake from wounds, after injection of radioactive particles into the
leg, the sinus or the maxillary bone and to compare the results with those obtained from alpha-emitters, in some experiments, also in the presence of cofactors.</p>

<p><strong>Status:</strong> 1975 - 1978 terminated; data in ERAD</p>

<p><strong>Treatment:</strong> Inhalation in a single session, intramuscular injection or injection into the maxillary, the sinus or the tooth of Ce-144 trichloride (or Ce-141 oxide or
trichloride adjusted to pH 5 for inhalation). </p>

<p><strong>Dosimetry:</strong> Mean initial activity inhaled or injected, measurement of lung burden 3 days after exposure, determination of organ activities at autopsies; dose
calculated from these data</p>

<p><strong>Endpoints:</strong> Life-span study (spontaneous death) with macroscopic/microscopic pathology.</p>

<p><strong>Animal:</strong> Male Sprague-Dawley SPF rats aged 3 months (one group 5 days); controls see 02.01</p>

<p><strong>Results: Inhalation of Ce-144 chloride </strong>at doses from 3 to 62 Gy caused a dose-dependent reduction in survival and an increase in lung cancers. When stable
Ce was added to retard the dissolving of the Ce hydroxide in the alveoli, the number of lung cancers increased significantly after doses from 15-54 Gy. The
cancers observed were mainly of the epidermoid type, but 1 osteosarcoma and 6 angiosarcoma were also observed.</p>

<p><strong>Inhalation of the oxide Ce-141</strong> (a -emitter of much lower energy than Ce-144 and the oxide of which is very insoluble in lung) caused lung cancers and
sarcoma in the dose range of 0.1-22 Gy. One third of the lung cancers were of the epidermoid type or adenocarcinomas, two third were bronchiolo-alveolar
carcinomas. These experiments demonstrated the (possibly synergistic) relation between radioactivity and masse and, especially, the influence of the
spatio-temporal distribution of the exposure on the histological type of lung cancers. </p>

<p><strong>Local administration</strong> was performed to study the induction of osteosarcomas, the time of appearance of tumors and the efficiency of therapeutic methods used
in man. The method used allowed to determine exactly the begin of the tumor development because the site of injection of the insoluble radioactive solution was
known. It was found that the incidence of metastasis, occurring mainly in lung, was comparable to that seen in man.</p>

<p><strong>References:</strong> Skupinski, W., R. Masse and J. Lafuma. Étude expérimentale de l'action de deux émetteurs beta inhalés: le cerium-144 et le cerium-141, pp. 35-44.
<em>In</em> IAEA-SM-202/404: <em>Biological and Environmental Effects of Low Level Radiation</em>, Vol. II. IAEA, Vienna, 1976.</p>

<p>Jasmin, J., C. Brocheriou, B. Klein, M. Morin and C. Jasmin. Induction in rats of paranasal sinus carcinomas with radioactive cerium chloride.<em> J. Natl. Cancer
Inst</em>.<strong> 58:</strong>423-427, 1977.</p>

<p>Jasmin, J., C. Brocheriou, M. Morin and C. Jasmin. Modèles expérimentaux de cancers de la cavité buccale. <em>Activités odonto-stomatologiques</em><strong> 118</strong>, 1977.</p>

<p>Klein, B., S. Pals, R. Masse, J. Lafuma, M. Morin, N. Binart, J.R. Jasmin and C. Jasmin. Studies of bone and soft tissue-tumors induced in rats by radioactive
cerium chloride.<em> Int. J. Cancer</em> <strong>20</strong>:112-119, 1977.</p>

<p>Jasmin, J., C. Brocheriou, A. Matar, M. Morin, C. Jasmin and J. Lafuma. Orofacial tumors induced in rats with radioactive cerium chloride. <em>Biomedicine</em>.<strong>
30</strong>:265-270, 1979.</p>

<p>Morin, M., R. Masse and J. Lafuma. Étude du radourcissement de la dureé de la vie et de la apparition de cancers in situ provoqueés par l'hydroxyde de
cérium-144 administré localement dans divers organes, pp. 301-313. <em>In</em> IAEA-Sm-237/33 [ed.], <em>Biological Implications of Radionuclides Released from
Nuclear Industries,</em> Vol. II. IAEA, Vienna, 1979.</p>

<p>Allouche, M., H. Delbruck, B. Klein, R. Masse, A. Matar, M. Morin, J. Lafuma and C. Jasmin. Malignant bone tumors induced by a local injection of colloidal
radioactive 144cerium in rats as a model for human osteosarcomas. <em>Int. J. Cancer</em><strong> 26</strong>:777-782, 1980.</p>

<p>Delbruck, H., M. Allouche, C. Jasmin and M. Morin. Bone tumors induced in rats with radioactive cerium. <em>Brit. J. Cancer</em> <strong>41</strong>:809-815, 1980.</p>

<p align="CENTER"><strong>Experimental Groups:</strong></p>

<p align="CENTER"><strong>Study 02.07: Lung and Sinus Tumors in Rats After Inhalation or Topical Injection of Ce-144 and Treatment with Different Cofactors </strong><br>
<br>

</p><center>
<table align="CENTER" border="1" width="100%" cellpadding="1" cellspacing="1">
<tbody><tr valign="BOTTOM"><td align="CENTER"><strong>Group Id</strong></td>
<td><strong>Compound Activity kBq (Gy)</strong></td>
<td><strong>Application</strong></td>
<td align="CENTER"><strong>No rats</strong></td></tr>
<tr valign="TOP"><td align="CENTER"><font color="#005000"><strong>1</strong></font></td>
<td><sup>144</sup>Ce Cl<sub>3</sub> 11 (3)</td>
<td>Inhalation</td>
<td align="CENTER">3</td></tr>
<tr valign="TOP"><td align="CENTER"><font color="#005000"><strong>2</strong></font></td>
<td><sup>144</sup>Ce Cl<sub>3</sub> 40 (11)</td>
<td>Inhalation</td>
<td align="CENTER">10</td></tr>
<tr valign="TOP"><td align="CENTER"><font color="#005000"><strong>3</strong></font></td>
<td><sup>144</sup>Ce Cl<sub>3</sub> 59 (16)</td>
<td>Inhalation</td>
<td align="CENTER">12</td></tr>
<tr valign="TOP"><td align="CENTER"><font color="#005000"><strong>4</strong></font></td>
<td><sup>144</sup>Ce Cl<sub>3</sub> 83 (22.5)</td>
<td>Inhalation</td>
<td align="CENTER">23</td></tr>
<tr valign="TOP"><td align="CENTER"><font color="#005000"><strong>5</strong></font></td>
<td><sup>144</sup>Ce Cl<sub>3</sub> 127 (33.5)</td>
<td>Inhalation</td>
<td align="CENTER">18</td></tr>
<tr valign="TOP"><td align="CENTER"><font color="#005000"><strong>6</strong></font></td>
<td><sup>144</sup>Ce Cl<sub>3</sub> 163 (42)</td>
<td>Inhalation</td>
<td align="CENTER">11</td></tr>
<tr valign="TOP"><td align="CENTER"><font color="#005000"><strong>7</strong></font></td>
<td><sup>144</sup>Ce Cl<sub>3</sub> 290 (62)</td>
<td>Inhalation</td>
<td align="CENTER">22</td></tr>
<tr valign="TOP"><td align="CENTER"><font color="#005000"><strong>8</strong></font></td>
<td><sup>144</sup>Ce Cl<sub>3</sub> 55 (15)</td>
<td>Inhalation +50 mg Ce stable</td>
<td align="CENTER">24</td></tr>
<tr valign="TOP"><td align="CENTER"><font color="#005000"><strong>9</strong></font></td>
<td><sup>144</sup>Ce Cl<sub>3</sub> 30 (22)</td>
<td>Inhalation +50 mg Ce stable</td>
<td align="CENTER">12</td></tr>
<tr valign="TOP"><td align="CENTER"><font color="#005000"><strong>10</strong></font></td>
<td><sup>144</sup>Ce Cl<sub>3</sub> 82 (54)</td>
<td>Inhalation +50 mg Ce stable</td>
<td align="CENTER">12</td></tr>
<tr valign="TOP"><td align="CENTER"><font color="#005000"><strong>11</strong></font></td>
<td><sup>141</sup>Ce oxide 2 (0.1) </td>
<td>Inhalation</td>
<td align="CENTER">3</td></tr>
<tr valign="TOP"><td align="CENTER"><font color="#005000"><strong>12</strong></font></td>
<td><sup>141</sup>Ce oxide 9 (0.3)</td>
<td>Inhalation</td>
<td align="CENTER">29</td></tr>
<tr valign="TOP"><td align="CENTER"><font color="#005000"><strong>13</strong></font></td>
<td><sup>141</sup>Ce oxide 42 (1.5)</td>
<td>Inhalation</td>
<td align="CENTER">10</td></tr>
<tr valign="TOP"><td align="CENTER"><font color="#005000"><strong>14</strong></font></td>
<td><sup>141</sup>Ce oxide 84 (3)</td>
<td>Inhalation</td>
<td align="CENTER">12</td></tr>
<tr valign="TOP"><td align="CENTER"><font color="#005000"><strong>15</strong></font></td>
<td><sup>141</sup>Ce oxide 165 (6)</td>
<td>Inhalation</td>
<td align="CENTER">12</td></tr>
<tr valign="TOP"><td align="CENTER"><font color="#005000"><strong>16</strong></font></td>
<td><sup>141</sup>Ce oxide 418 (15)</td>
<td>Inhalation</td>
<td align="CENTER">24</td></tr>
<tr valign="TOP"><td align="CENTER"><font color="#005000"><strong>17</strong></font></td>
<td><sup>141</sup>Ce oxide 608 (22)</td>
<td>Inhalation</td>
<td align="CENTER">12</td></tr>
<tr valign="TOP"><td align="CENTER"><font color="#005000"><strong>18</strong></font></td>
<td><sup>141</sup>Ce Cl<sub>3</sub> 42 (1.2)</td>
<td>Inhalation</td>
<td align="CENTER">36</td></tr>
<tr valign="TOP"><td align="CENTER"><font color="#005000"><strong>19</strong></font></td>
<td><sup>141</sup>Ce57 (1.8)</td>
<td>Inhalation</td>
<td align="CENTER">12</td></tr>
<tr valign="TOP"><td align="CENTER"><font color="#005000"><strong>20</strong></font></td>
<td><sup>141</sup>Ce Cl<sub>3</sub> 3 129 (30)</td>
<td>Inhalation</td>
<td align="CENTER">12</td></tr>
<tr valign="TOP"><td align="CENTER"><font color="#005000"><strong>21</strong></font></td>
<td><sup>144</sup>Ce Cl<sub>3</sub> 110</td>
<td>IM Injection (Wistar)</td>
<td align="CENTER">11</td></tr>
<tr valign="TOP"><td align="CENTER"><font color="#005000"><strong>22</strong></font></td>
<td><sup>144</sup>Ce Cl<sub>3</sub> 155</td>
<td>IM Injection (Wistar)</td>
<td align="CENTER">50</td></tr>
<tr valign="TOP"><td align="CENTER"><font color="#005000"><strong>23</strong></font></td>
<td><sup>144</sup>Ce Cl<sub>3</sub> 155</td>
<td>IM Injection</td>
<td align="CENTER">40</td></tr>
<tr valign="TOP"><td align="CENTER"><font color="#005000"><strong>24</strong></font></td>
<td><sup>144</sup>Ce Cl<sub>3</sub> 215</td>
<td>IM Injection </td>
<td align="CENTER">75</td></tr>
<tr valign="TOP"><td align="CENTER"><font color="#005000"><strong>25</strong></font></td>
<td><sup>144</sup>Ce Cl<sub>3</sub> 315</td>
<td>IM Injection </td>
<td align="CENTER">12</td></tr>
<tr valign="TOP"><td align="CENTER"><font color="#005000"><strong>26</strong></font></td>
<td><sup>144</sup>Ce Cl<sub>3</sub> 1600</td>
<td>IM Injection </td>
<td align="CENTER">8</td></tr>
<tr valign="TOP"><td align="CENTER"><font color="#005000"><strong>27</strong></font></td>
<td><sup>144</sup>Ce Cl<sub>3</sub> 2.6</td>
<td>IM Injection (5 day old)</td>
<td align="CENTER">20</td></tr>
<tr valign="TOP"><td align="CENTER"><font color="#005000"><strong>28</strong></font></td>
<td><sup>144</sup>Ce Cl<sub>3</sub> 185</td>
<td>IM Inj.+ saline</td>
<td align="CENTER">40</td></tr>
<tr valign="TOP"><td align="CENTER"><font color="#005000"><strong>29</strong></font></td>
<td><sup>144</sup>Ce Cl<sub>3</sub> 1600</td>
<td>IM Inj.+ 15mg/kg Endoxan 2*/month</td>
<td align="CENTER">8</td></tr>
<tr valign="TOP"><td align="CENTER"><font color="#005000"><strong>30</strong></font></td>
<td><sup>144</sup>Ce Cl<sub>3</sub> 1600</td>
<td>IM Inj.+ 1mg/kg Imuran 2*/month</td>
<td align="CENTER">8</td></tr>
<tr valign="TOP"><td align="CENTER"><font color="#005000"><strong>31</strong></font></td>
<td><sup>144</sup>Ce Cl<sub>3</sub> 1600</td>
<td>IM Inj.+ 1U/rat Calcitar 2*/month</td>
<td align="CENTER">9</td></tr>
<tr valign="TOP"><td align="CENTER"><font color="#005000"><strong>32</strong></font></td>
<td><sup>144</sup>Ce Cl<sub>3</sub> 1600</td>
<td>IM Inj.+ 9.25 kBq <sup>241</sup>Am </td>
<td align="CENTER">8</td></tr>
<tr valign="TOP"><td align="CENTER"><font color="#005000"><strong>33</strong></font></td>
<td><sup>144</sup>Ce Cl<sub>3</sub> 1660</td>
<td>IM Inj. + Amput.+Interferon</td>
<td align="CENTER">40</td></tr>
<tr valign="TOP"><td align="CENTER"><font color="#005000"><strong>34</strong></font></td>
<td><sup>144</sup>Ce Cl<sub>3</sub> 1.85</td>
<td>Intramaxill.</td>
<td align="CENTER">21</td></tr>
<tr valign="TOP"><td align="CENTER"><font color="#005000"><strong>35</strong></font></td>
<td><sup>144</sup>Ce Cl<sub>3</sub> 1.85</td>
<td>Intramaxill. (5 day old)</td>
<td align="CENTER">61</td></tr>
<tr valign="TOP"><td align="CENTER"><font color="#005000"><strong>36</strong></font></td>
<td><sup>141</sup>Ce Cl<sub>3</sub> 185</td>
<td>Intramaxill.+ 296 kBq <sup>144</sup>Ce </td>
<td align="CENTER">61</td></tr>
<tr valign="TOP"><td align="CENTER"><font color="#005000"><strong>37</strong></font></td>
<td><sup>141</sup>Ce Cl<sub>3</sub> 185</td>
<td>Intramaxill. + 13 kBq <sup>241</sup>Am </td>
<td align="CENTER">20</td></tr>
<tr valign="TOP"><td align="CENTER"><font color="#005000"><strong>38</strong></font></td>
<td><sup>141</sup>Ce Cl<sub>3</sub> 0.74</td>
<td>Intrasinusal</td>
<td align="CENTER">13</td></tr>
<tr valign="TOP"><td align="CENTER"><font color="#005000"><strong>39</strong></font></td>
<td><sup>141</sup>Ce Cl<sub>3</sub> 4.44</td>
<td>Intrasinusal</td>
<td align="CENTER">12</td></tr>
<tr valign="TOP"><td align="CENTER"><font color="#005000"><strong>40</strong></font></td>
<td><sup>141</sup>Ce Cl<sub>3</sub> 18.5</td>
<td>Intrasinusal</td>
<td align="CENTER">12</td></tr>
<tr valign="TOP"><td align="CENTER"><font color="#005000"><strong>41</strong></font></td>
<td><sup>141</sup>Ce Cl<sub>3</sub> 166</td>
<td>Intrasinusal</td>
<td align="CENTER">12</td></tr>
<tr valign="TOP"><td align="CENTER"><font color="#005000"><strong>42</strong></font></td>
<td><sup>141</sup>Ce Cl<sub>3</sub> 18.5</td>
<td>Intradental</td>
<td align="CENTER">13</td></tr>
<tr valign="TOP"><td colspan="3" align="CENTER"><b>Total</b></td>
<td align="CENTER"><b>863</b></td></tr></tbody></table>
</center>
&nbsp;


			<a href="https://era.bfs.de/studies_details.php?LabId=2&StudyId=7">Please click here to view the 'live' data in ERA</a><br> 
			<p></p>
			
		</div>
	</div>

	
	<div id="supportingText">
		<div id="explanation">
			<h3><span></span></h3>
			<p class="p1"><span><!--More text here --></span></p>
		</div>

		<div id="footer">
			A co-operation between the <a href="http://www.bfs.de/">Federal Office for Radiation Protection, Germany</a> and the <a href="http://www.cam.ac.uk/">University of Cambridge, England</a>. Funded by the EU's EURATOM FP6 framework programme. © BfS
		</div>

	</div>
	<!--	<div id="linkList">
		<div id="linkList2">
			<div id="lselect">
				<h3 class="select"><span>About ERA:</span></h3>
				<ul>
					<li><a href="contacts.php">Contacts</a></li>
					<li><a href="advisoryboard.php">Advisory Board</a></li>
					<li><a href="wiki.php">News</a></li>
					<li><a href="toc.php">Terms and Conditions</a></li>

				</ul>
			</div>

			<div id="larchives">
				<h3 class="archives"><span>Resources:</span></h3>
				<ul>
					<li><a href="publications.php">ERA Publications</a></li>
					<li><a href="http://www.pathbase.net/zoomify/era_index.php">High resolution images</a></li>
					<li><a href="statistics.php">ERA Statistics</a></li>
					<li><a href="webservices.php">Webservices</a></li>
				</ul>
			</div>
			<div id="lresources">
				<h3 class="resources"><span>News from ERRS:</span></h3>
				<ul>
					<li>no news from errs at the moment.</li>					<li><a href="http://www.euradnews.org" title="The latest from www.euradnews.org">More news from ERRS</a></li>
					

				</ul>
			</div>
		</div>
	</div>
	-->

</div>
<div id="navtxt" class="navtext" style="position: absolute; top: -100px; left: 0px; visibility: hidden; padding: 4px;"></div>



</body></html>